Relationships with the drug industry: Build trust based on good scienceBMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.b234 (Published 04 February 2009) Cite this as: BMJ 2009;338:b234
- Scott Gottlieb, health policy analyst
- 1American Enterprise Unit, 1150 17th Street, NW, Washington, DC 20036, USA
Medical treatments are becoming increasingly more individual, with respect to both disease and patient. They are also becoming more complex, and precise diagnoses and close monitoring are needed to optimise …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial